Pro Dex (PDEX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $60.02, +0.33% vs the prior close of $59.82.
- Volume 31.90K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PDEX rises 0.3% to $60.02. Closed at $60.02, +0.33% vs the prior close of $59.82. Day range $59.15–$60.99, opened at $59.61.
PDEX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — PDEX rises 0.3% to $60.02
- Closed at $60.02, +0.33% vs the prior close of $59.82. Day range $59.15–$60.99, opened at $59.61.
- Volume was 31.90K shares, 0.5x its 50-day average of 69.64K — lighter than usual.
- Price is -9.2% vs its 50-day average ($66.12) and +8.3% vs its 200-day average ($55.44).
- 52-week range $23.47–$77.00; today's close sits at 68% of that range, 22.1% below the 52-week high.
Oct 14, 2026 — PDEX slides 3.9% to $59.82, a 1-month low
- Closed at $59.82, -3.93% vs the prior close of $62.27. Day range $59.57–$62.75, opened at $61.88.
- Volume was 61.50K shares, 0.9x its 50-day average of 70.05K.
- Price is -9.7% vs its 50-day average ($66.24) and +8.1% vs its 200-day average ($55.34).
- 52-week range $23.47–$77.00; today's close sits at 68% of that range, 22.3% below the 52-week high.
Oct 13, 2026 — PDEX dips 1.3% to $62.27
- Closed at $62.27, -1.30% vs the prior close of $63.09. Day range $61.95–$63.12, opened at $62.85.
- Volume was 29.10K shares, 0.4x its 50-day average of 71.09K — lighter than usual.
- Price is -6.2% vs its 50-day average ($66.41) and +12.7% vs its 200-day average ($55.23).
- 52-week range $23.47–$77.00; today's close sits at 72% of that range, 19.1% below the 52-week high.
Oct 12, 2026 — PDEX rises 1.0% to $63.09
- Closed at $63.09, +0.96% vs the prior close of $62.49. Day range $62.00–$63.97, opened at $62.30.
- Volume was 66.50K shares, 0.9x its 50-day average of 71.12K.
- Price is -5.0% vs its 50-day average ($66.44) and +14.4% vs its 200-day average ($55.13).
- 52-week range $23.47–$77.00; today's close sits at 74% of that range, 18.1% below the 52-week high.
Oct 9, 2026 — PDEX rises 0.5% to $62.49
- Closed at $62.49, +0.45% vs the prior close of $62.21. Day range $61.80–$63.73, opened at $63.05.
- Volume was 31.90K shares, 0.4x its 50-day average of 71.90K — lighter than usual.
- Price is -5.8% vs its 50-day average ($66.35) and +13.6% vs its 200-day average ($55.02).
- 52-week range $23.47–$77.00; today's close sits at 73% of that range, 18.8% below the 52-week high.
Oct 8, 2026 — PDEX dips 0.9% to $62.21, 3 down days in a row
- Closed at $62.21, -0.94% vs the prior close of $62.80. Day range $60.54–$63.80, opened at $63.16.
- Volume was 46.70K shares, 0.6x its 50-day average of 72.13K.
- Price is -6.1% vs its 50-day average ($66.23) and +13.3% vs its 200-day average ($54.92).
- 52-week range $23.47–$77.00; today's close sits at 72% of that range, 19.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — PDEX slides 3.3% to $62.80
- Closed at $62.80, -3.27% vs the prior close of $64.92. Day range $62.35–$64.75, opened at $64.03.
- Volume was 44.30K shares, 0.6x its 50-day average of 73.32K.
- Price is -5.0% vs its 50-day average ($66.09) and +14.6% vs its 200-day average ($54.80).
- 52-week range $23.47–$77.00; today's close sits at 73% of that range, 18.4% below the 52-week high.
Oct 6, 2026 — PDEX dips 0.7% to $64.92
- Closed at $64.92, -0.75% vs the prior close of $65.41. Day range $64.03–$66.85, opened at $65.04.
- Volume was 70.10K shares, 1.0x its 50-day average of 73.65K.
- Price is -1.6% vs its 50-day average ($65.96) and +18.7% vs its 200-day average ($54.70).
- 52-week range $23.47–$77.00; today's close sits at 77% of that range, 15.7% below the 52-week high.
- SEC filings that day: DEF 14A.
Oct 5, 2026 — PDEX rises 2.1% to $65.41
- Closed at $65.41, +2.09% vs the prior close of $64.07. Day range $63.45–$67.00, opened at $63.98.
- Volume was 44.10K shares, 0.6x its 50-day average of 74.70K — lighter than usual.
- Price is -0.6% vs its 50-day average ($65.80) and +19.8% vs its 200-day average ($54.59).
- 52-week range $23.47–$77.00; today's close sits at 78% of that range, 15.1% below the 52-week high.
Oct 2, 2026 — PDEX dips 2.0% to $64.07, 6 down days in a row
- Closed at $64.07, -1.97% vs the prior close of $65.36. Day range $63.74–$66.95, opened at $66.60.
- Volume was 35.30K shares, 0.5x its 50-day average of 74.95K — lighter than usual.
- Price is -2.3% vs its 50-day average ($65.59) and +17.6% vs its 200-day average ($54.48).
- 52-week range $23.47–$77.00; today's close sits at 76% of that range, 16.8% below the 52-week high.
- That makes 6 straight losses.
PDEX latest news & SEC filings
Every SEC filing by or about PDEX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Oct 6, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 6, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Van Kirk Richard Lee Jr sold 475 shares at $59.62 (≈$28.32K) on Sep 11, 2026
- Van Kirk Richard Lee Jr sold 290 shares at $58.94 (≈$17.09K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Van Kirk Richard Lee Jr sold 2,160 shares at $58.92 (≈$127.27K) on Sep 9, 2026
- Van Kirk Richard Lee Jr sold 2,691 shares at $59.84 (≈$161.03K) on Sep 9, 2026
- Van Kirk Richard Lee Jr sold 4,274 shares at $60.72 (≈$259.52K) on Sep 9, 2026
- Van Kirk Richard Lee Jr sold 1,157 shares at $61.88 (≈$71.60K) on Sep 9, 2026
- Van Kirk Richard Lee Jr sold 4,768 shares at $59.45 (≈$283.46K) on Sep 9, 2026
- Van Kirk Richard Lee Jr sold 2,144 shares at $63.85 (≈$136.89K) on Sep 9, 2026
- …plus 3 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Charlton Alisha sold 800 shares at $61.76 (≈$49.41K) on Sep 9, 2026
- Charlton Alisha sold 1,500 shares at $61.05 (≈$91.58K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 3, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $77.55M (prior year $66.59M) (+16.5% vs Jun 30, 2025)
- Net income: $13.66M (prior year $8.98M) (+52.2% vs Jun 30, 2025)
- Diluted EPS: $4.12 (prior year $2.67) (+54.3% vs Jun 30, 2025)
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade PDEX
- Last results release: Sep 3, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Jan 29, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Dec 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.68% (largest 5.3%).
- Liquidity: about 55.34K shares (≈$3.32M) trade per day on average.
- 52-week position: $60.02 vs a range of $23.47–$77.00 (68% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 20 sales; latest: Kirk Richard Lee Jr Van sold 475 shares on Sep 11, 2026.
- Latest filings: 8-K Sep 18, 2026; 8-K Sep 3, 2026; 10-K Sep 3, 2026.
- Share count: 3.20M shares outstanding (Sep 2, 2026), -1.8% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
PDEX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 59.61 | 60.99 | 59.15 | 60.02 | 31.90K |
| Oct 14, 2026 | 61.88 | 62.75 | 59.57 | 59.82 | 61.50K |
| Oct 13, 2026 | 62.85 | 63.12 | 61.95 | 62.27 | 29.10K |
| Oct 12, 2026 | 62.30 | 63.97 | 62.00 | 63.09 | 66.50K |
| Oct 9, 2026 | 63.05 | 63.73 | 61.80 | 62.49 | 31.90K |
| Oct 8, 2026 | 63.16 | 63.80 | 60.54 | 62.21 | 46.70K |
| Oct 7, 2026 | 64.03 | 64.75 | 62.35 | 62.80 | 44.30K |
| Oct 6, 2026 | 65.04 | 66.85 | 64.03 | 64.92 | 70.10K |
| Oct 5, 2026 | 63.98 | 67.00 | 63.45 | 65.41 | 44.10K |
| Oct 2, 2026 | 66.60 | 66.95 | 63.74 | 64.07 | 35.30K |
| Oct 1, 2026 | 68.74 | 69.01 | 64.56 | 65.36 | 42.80K |
| Sep 30, 2026 | 70.44 | 70.44 | 68.10 | 69.00 | 60.50K |
| Sep 29, 2026 | 71.62 | 71.69 | 68.58 | 70.02 | 50.80K |
| Sep 28, 2026 | 71.53 | 73.00 | 70.56 | 71.62 | 92.30K |
| Sep 25, 2026 | 73.09 | 74.20 | 70.85 | 71.77 | 60.00K |
| Sep 24, 2026 | 70.81 | 74.00 | 70.80 | 73.02 | 39.50K |
| Sep 23, 2026 | 72.38 | 72.76 | 70.52 | 71.94 | 96.40K |
| Sep 22, 2026 | 72.84 | 73.50 | 71.97 | 72.41 | 42.40K |
| Sep 21, 2026 | 72.70 | 73.40 | 71.20 | 72.52 | 75.90K |
| Sep 18, 2026 | 70.29 | 73.29 | 69.56 | 72.55 | 84.70K |
About Pro Dex
Pro Dex (PDEX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in IRVINE, CA. Fiscal year ends June 30. SEC CIK 788920.
PDEX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Raymond E Cabillot | Director | Nov 21, 2025 |
| Angelita Rebamontan Domingo | Director | Jul 24, 2026 |
| William James Iii Farrell | Director | Nov 21, 2025 |
| David Hovda | Director | Nov 21, 2025 |
| Katrina Marie Kramer Philp | Director | Nov 24, 2025 |
| Nicholas John Swenson | Director | Nov 21, 2025 |
| Kirk Richard Lee Jr Van | Chief Executive Officer | Sep 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Alisha Charlton | Chief Financial Officer | Sep 10, 2026 |
| Kirk Richard Lee Jr Van | Chief Executive Officer | Sep 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Kirk Richard Lee Jr Van | Sale | 475 | $59.62 |
| Sep 11, 2026 | Kirk Richard Lee Jr Van | Sale | 290 | $58.94 |
| Sep 9, 2026 | Alisha Charlton | Sale | 800 | $61.76 |
| Sep 9, 2026 | Alisha Charlton | Sale | 1,500 | $61.05 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 2,160 | $58.92 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 2,691 | $59.84 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 4,274 | $60.72 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 1,157 | $61.88 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 4,768 | $59.45 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 2,144 | $63.85 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 300 | $64.70 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 806 | $58.66 |
| Sep 9, 2026 | Kirk Richard Lee Jr Van | Sale | 935 | $62.93 |
| May 22, 2026 | Kirk Richard Lee Jr Van | Sale | 2,824 | $62.09 |
| May 22, 2026 | Kirk Richard Lee Jr Van | Sale | 1,254 | $62.93 |
PDEX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $77.55M | $13.66M | 4.12 | $7.24M |
| Jun 30, 2025 | $66.59M | $8.98M | 2.67 | $-1.68M |
| Jun 30, 2024 | $53.84M | $2.13M | 0.60 | $6.22M |
| Jun 30, 2023 | $46.09M | $7.07M | 1.95 | $5.46M |
| Jun 30, 2022 | $42.04M | $4.57M | 1.21 | $-847.00K |
Latest balance sheet: total assets $74.51M, total liabilities $26.88M, cash $8.19M (as of Jun 30, 2026).
PDEX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 3, 2026 | 8-K Item 2.02 (results) | $61.75 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $50.14 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $39.41 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $30.63 |
| Sep 4, 2025 | 8-K Item 2.02 (results) | $45.74 |
| May 1, 2025 | 8-K Item 2.02 (results) | $67.30 |
| Jan 30, 2025 | 8-K Item 2.02 (results) | $42.95 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $31.02 |
| Sep 5, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on PDEX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.